Natural Product (NP) Details
| General Information of the NP (ID: NP8268) | |||||
|---|---|---|---|---|---|
| Name |
Curcumol
|
||||
| Synonyms |
(-)-Curcumol; 4871-97-0; UNII-9190RTN07X; 9190RTN07X; MFCD00272163; (3S,3aS,5S,6R,8aS)-Octahydro-3-methyl-8-methylene-5-(1-methylethyl)-6H-3a,6-epoxyazulen-6-ol; 5,8-Epoxy-10(14)-guaien-8-ol; ( -)-Curcumol; CHEMBL4303567; SCHEMBL22404924; HY-N0104; ( -)-Curcumol, analytical standard; s2407; ZINC70466453; AKOS022168205; CCG-266844; NCGC00346607-02; BS-16857; V0174; 871C970; Q-100546; Q27271386; (1S,2S,5S,8R,9S)-2-methyl-6-methylidene-9-propan-2-yl-11-oxatricyclo[6.2.1.01,5]undecan-8-ol; (3S-(3alpha,3aalpha,5alpha,6alpha,8abeta))-Octahydro-3-methyl-8-methylene-5-(1-methylethyl)-6H-3a,6-epoxyazulen-6-ol; 6H-3a,6-Epoxyazulen-6-ol, octahydro-3-methyl-8-methylene-5-(1-methylethyl)-, (3S,3aS,5S,6R,8aS)-
Click to Show/Hide
|
||||
| Species Origin | Halicephalobus sp. hali_val ... | Click to Show/Hide | |||
| Halicephalobus sp. hali_val | |||||
| Disease | Mucositis [ICD-11: CA00] | Phase 3 | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| ADMET Property |
Absporption
Caco-2 Permeability
-4.714
MDCK Permeability
-4.648
PAMPA
- - -
HIA
- - -
Distribution
VDss
0.625
PPB
93.2%
BBB
- - -
Metabolism
CYP1A2 inhibitor
- -
CYP1A2 substrate
- - -
CYP2C19 inhibitor
- - -
CYP2C19 substrate
+++
CYP2C9 inhibitor
-
CYP2C9 substrate
- -
CYP2D6 inhibitor
- -
CYP2D6 substrate
- - -
CYP3A4 inhibitor
-
CYP3A4 substrate
+
CYP2B6 inhibitor
+
CYP2B6 substrate
- - -
CYP2C8 inhibitor
+++
HLM Stability
-
Excretion
CLplasma
8.895
T1/2
1.78
Toxicity
DILI
- -
Rat Oral Acute Toxicity
+
FDAMDD
-
Respiratory
+
Human Hepatotoxicity
+
Ototoxicity
+
Drug-induced Nephrotoxicity
-
Drug-induced Neurotoxicity
-
Hematotoxicity
- -
Genotoxicity
- -
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++).
2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
Click to Show/Hide
|
||||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C15H24O2
|
||||
| PubChem CID | |||||
| Canonical SMILES |
CC1CCC2C13CC(C(O3)(CC2=C)O)C(C)C
|
||||
| InChI |
1S/C15H24O2/c1-9(2)13-8-14-11(4)5-6-12(14)10(3)7-15(13,16)17-14/h9,11-13,16H,3,5-8H2,1-2,4H3/t11-,12-,13-,14-,15+/m0/s1
|
||||
| InChIKey |
QRMPRVXWPCLVNI-YYFQZIEXSA-N
|
||||
| CAS Number |
CAS 4871-97-0
|
||||
| Herb ID | |||||
| ETMC ID | |||||
| SymMap ID | |||||
| TCMSP ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Resistance can be Reversed by This NP | ||||||
| TNF-related apoptosis inducing ligand | Lung cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
| Reversing Drug Resistance | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
|
| Down-regulation | Expression | NQO2 | Molecule Info | |||
| Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | A-549 | CVCL_0023 | Lung adenocarcinoma | Homo sapiens | ||
| NCI-H1299 | CVCL_0060 | Lung large cell carcinoma | Homo sapiens | |||
| NCI-H1975 | CVCL_1511 | Lung adenocarcinoma | Homo sapiens | |||
| NCI-H358 | CVCL_1559 | Lung adenocarcinoma | Homo sapiens | |||
| NCI-H460 | CVCL_0459 | Lung large cell carcinoma | Homo sapiens | |||
| In-vivo Model | BALB/c nude mice (5-week-old) were subcutaneously inoculated with A549 cells (1*106). | |||||
| Experimental
Result(s) |
Curcumol overcomes TRAIL resistance of non-small cell lung cancer by targeting NRH:Quinone Oxidoreductase 2 (NQO2). | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Receptor-interacting protein 1 (RIPK1) | Molecule Info | [3] | |
| Receptor-interacting protein 3 (RIPK3) | Molecule Info | [3] | ||